Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The dual agonist mechanism provides robust glycemic control and significant weight reduction, with clinical trials demonstrating A1C reductions of 1.92.4% and weight loss of approximately 1522% of body weight in non-diabetic adults with obesity (SURMOUNT-1 trial), with more modest weight loss typically observed in patients with type 2 diabetes
Biomaterials science
Claimed outcome Energy changes Evidence level Preclinical or anecdotal What research currently shows NAD+ biology offers a possible mechanism, and informal reports vary
For a 5mg vial reconstituted with 2mL bacteriostatic water: 5mg 2mL = 2.5mg/mL concentration
If you have a question that isn't here, our team will answer in under an hour
US$ 21.85
US$ 25.51
US$ 26.66
US$ 25.33
